Clinical Trials in Detroit

Showing 4521-4540 of 19,719 trials

HPC Offered for PRESERVE Expansion

NCT07145411

Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product

Bone Marrow Transplant (BMT)

Ossium Health, Inc.10 participantsStarted Jun 2024

Birmingham, Alabama, United States • Detroit, Michigan, United States • Columbus, Ohio, United States +1 more locations

COMPLETEDPhase 3< 1 mile

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

NCT04209855

This Phase 3 study is designed to compare the efficacy and safety of mirvetuximab soravtansine (MIRV) vs. IC chemotherapy in participants with platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer, whose tumors express a high-level of FRα. Participants will be, in the opinion of the Investigator, appropriate for single-agent therapy for their next line of therapy. The FRα positivity will be defined by the Ventana FOLR1 (FOLR1-2.1) CDx assay.

Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer

AbbVie453 participantsStarted Dec 2019

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Phoenix, Arizona, United States +211 more locations

HPC Offered for PRESERVE Expansion

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

Find Trials by Condition in Detroit

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

Optimizing Dimensions of Reinforcement

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

Study of Uterine Prolapse Procedures - Randomized Trial

Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus

Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

Resiliency in U.S. Air Force Personnel

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Symptom Management Implementation of Patient Reported Outcomes in Oncology

Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

MarginProbe 2.0 Data Collection Protocol

Multicenter Study to Evaluate the Clinical Outcome of PrimeTaper EV Implant in Single Tooth Restorations

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis